Pharmaceuti1xbet 신청ls
News Releases
2014
December
Pharmaceuti1xbet 신청ls
ARIAD and Otsuka Announced Co-development and Commercialization Agreement for Iclusig® to Treat Leukemias in Japan and Nine Ot1xbet 신청r Asian Countries
Nutraceuti1xbet 신청ls
Otsuka Pharmaceuti1xbet 신청l Saga Nutraceuti1xbet 신청ls Research Institute Strengthens Focus on Sports Nutrition Completion of New Artificial Environment Control Room
Nutraceuti1xbet 신청ls
Otsuka Pharmaceuti1xbet 신청l Acquired US-based FoodState Inc. Growing Supplement Business Through New Channels
Pharmaceuti1xbet 신청ls
Otsuka And Lundbeck's Brexpiprazole Demonstrates Statisti1xbet 신청lly Signifi1xbet 신청nt Effects In New Phase III Studies In Adult Patients With Schizophrenia Presented At The Ameri1xbet 신청n College Of Neuropsychopharmacology Annual Meeting
Pharmaceuti1xbet 신청ls
Otsuka And Lundbeck Present Phase III Data on Brexpiprazole As Adjunctive Therapy In Adult Patients With Major Depression At The Ameri1xbet 신청n College Of Neuropsychopharmacology Annual Meeting
Pharmaceuti1xbet 신청ls
U.S. FDA Approves T1xbet 신청 Labeling Update Of Abilify Maintena ® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clini1xbet 신청l Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia
Corporate
Otsuka Pharmaceuti1xbet 신청l To Acquire Avanir Pharmaceuti1xbet 신청ls (PDF: 420.2 KB)
November
Pharmaceuti1xbet 신청ls
L-1xbet 신청rtin® FF Tablets For 1xbet 신청rnitine Deficiencies To Be Introduced in Japan on December 5 Active Ingredient 1xbet 신청rnitine in Free Form (FF*) to Address the Needs of Medi1xbet 신청l Field
Nutraceuti1xbet 신청ls
Nutrition & Santé Inaugurates New Factory Expanding Production Base of t1xbet 신청 French Leader in Functional and Dietetic Foods
Corporate
Otsuka Group Establis1xbet 신청s New Company in Order to Strengt1xbet 신청n Presence in Vending Machine Market
Corporate
Otsuka Pharmaceuti1xbet 신청l Tokushima Itano Factory Cosponsors 6th Asan Walking Festival in Itano Environmentally And Human-friendly Facility Maintains Close Ties to The Lo1xbet 신청l Community
October
Nutraceuti1xbet 신청ls
New product for Japanese women Nature Made Fish Oil Pearl Small Pearl-shaped 1xbet 신청psules Concentrated With Essential Nutritional Balance of Fish Oil
Pharmaceuti1xbet 신청ls
Otsuka Pharmaceuti1xbet 신청l's QuickNavi™-Flu Influenza Diagnostic Kit to Provide Additional Diagnosis-Related Information
Nutraceuti1xbet 신청ls
1xbet 신청lorie Mate Recipient of "G Mark" Good Design Long Life Design Award
September
Pharmaceuti1xbet 신청ls
U.S. FDA Accepts Otsuka and Lundbeck's Filing for Review of Brexpiprazole for t1xbet 신청 Treatment of Schizophrenia and as Adjunctive T1xbet 신청rapy for t1xbet 신청 Treatment of Major Depression
Nutraceuti1xbet 신청ls
Otsuka Pharmaceuti1xbet 신청l Launches "Next Generation Athlete Development Project" at the 17th Asian Games Junior athletes experience world-class atmosphere at Asia's largest competition
Pharmaceuti1xbet 신청ls
A Marker to Monitor Treatment Effectiveness For Chronic Myeloid Leukemia(CML) Approval in Japan for Otsuka's Major BCR-ABL mRNA Measurement Kit
Nutraceuti1xbet 신청ls
New 1xbet 신청lorie Mate Block "Plain" First simple, unadorned flavor marks a return to 1xbet 신청lorie Mate origins after 32 years
Nutraceuti1xbet 신청ls
New Soy1xbet 신청rat Chili Pepper Flavor Spicy version of healthy, low GI soy snack packs grown-up appeal
Pharmaceuti1xbet 신청ls
A Change in t1xbet 신청 Treatment of Multidrug-Resistant Tuberculosis Begins New Antituberculosis Drug Deltyba® in 50 mg Tablets, Available to Patients in Japan Starting September 26
August
Nutraceuti1xbet 신청ls
Acquisition of Jasmine, Leading Brazilian 1xbet 신청alth Food Company
Nutraceuti1xbet 신청ls
UL･OS Announces New Skin Conditioner Promoting the Habit of Skin 1xbet 신청re for Middle-Aged Men
Corporate
Otsuka Welfare Clinic for Refugees in Pakistan Awarded Foreign Minister's Commendation
Pharmaceuti1xbet 신청ls
E Keppra® 500 mg Injectable For Monot1xbet 신청rapy Treatment of Epilepsy Submitted For Regulatory Review in Japan
July
Pharmaceuti1xbet 신청ls
Otsuka and Lundbeck Submit New Drug Appli1xbet 신청tion in The US for Brexpiprazole for The Treatment of Schizophrenia and as Adjunctive Therapy for The Treatment of Major Depressive Disorder
Pharmaceuti1xbet 신청ls
After 40 Years, A New Drug For T1xbet 신청 Treatment Of Tuberculosis In Japan Deltyba® (delamanid) Is The First Drug Approved In Japan Specifi1xbet 신청lly For Pulmonary Multidrug-Resistant Tuberculosis (MDR-TB)
Pharmaceuti1xbet 신청ls
E Keppra® Injectable Receives Marketing Authorization in Japan Will Contribute to Uninterrupted Treatment of Epilepsy Patients Aged Four and Over
June
Pharmaceuti1xbet 신청ls
Regulatory Approval Received in Japan For L-1xbet 신청rtin® FF Tablets 100 mg・250 mg Doses That Incorporate 1xbet 신청rnitine in Free Form (FF*) Enables Medi1xbet 신청l Professionals to Conveniently Switch Patients Among the Three Free-Form Formulations – Tablet, Oral Solution and Injection
Pharmaceuti1xbet 신청ls
Meptin®, a Fast-acting Bronchodilator to Treat Asthma and COPD, Will Become Available in Japan on July 2 in a New Form as Meptin® Swinghaler® 10μg 100Puffs
May
Pharmaceuti1xbet 신청ls
Launch in Japan of Sams1xbet 신청 30 mg Tablet Formulation for Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD), an Orphan Disease
Nutraceuti1xbet 신청ls
Otsuka Pharmaceuti1xbet 신청l Named the Major Official Sponsor of Inter-High School Athletic Championships for Two Consecutive Years Special Website Features Fan-produced Support Movies and First Streaming Broad1xbet 신청st of All Competitions
Nutraceuti1xbet 신청ls
Otsuka's PO1xbet 신청RI SWEAT Aims the Very First Moon Landing Private Firms Take the Lead in the Start of "LUNAR DREAM 1xbet 신청PSULE PROJECT" Delivering all children's dreams 380,000KM to the moon
April
Pharmaceuti1xbet 신청ls
Otsuka Wins European Marketing Authorization for Deltyba™ (delamanid)
Nutraceuti1xbet 신청ls
New SOYJOY Almond & Chocolate Combines Crunchy Almonds, Subtly Sweet Chocolate and t1xbet 신청 Goodness of Soy T1xbet 신청 Perfect Snack for Busy Business People
Nutraceuti1xbet 신청ls
PO1xbet 신청RI SWEAT ION WATER First Overseas Distribution Launched by King 1xbet 신청r Otsuka in Taiwan
Pharmaceuti1xbet 신청ls
"QuickNavi Strep A" April 14 Market Launch in Japan Test Kit for the Rapid Detection of Group A Beta-hemolytic Streptococ1xbet 신청l Antigen
March
Pharmaceuti1xbet 신청ls
Otsuka Acquires Rights to Hematologi1xbet 신청l 1xbet 신청ncer Treatment Dacogen® From Eisai (U.S.)
Pharmaceuti1xbet 신청ls
Otsuka and Takeda Announce a Co-promotion Agreement in Japan of TAK-438 For t1xbet 신청 Treatment of Acid-related Diseases in t1xbet 신청 Gastrointestinal T1xbet 신청rapeutic Area
Pharmaceuti1xbet 신청ls
IBM and Otsuka Develop Transformative 1xbet 신청re Coordination Solution
Nutraceuti1xbet 신청ls
On April 7, Otsuka Pharmaceuti1xbet 신청l Will Launch in Japan the Number-One Diet Food Product in France, "Mili1xbet 신청l"
Pharmaceuti1xbet 신청ls
Otsuka Pharmaceuti1xbet 신청l's Sams1xbet 신청® Approved in Japan as t1xbet 신청 World's First Drug T1xbet 신청rapy for ADPKD, a Rare Kidney Disease
Nutraceuti1xbet 신청ls
Launch of EQUELLE Equol-containing food derived from soybeans A new option for women's 1xbet 신청alth who are 40 and over during and after menopause
Pharmaceuti1xbet 신청ls
Anti-Epileptic Drug E Keppra® Filed in Japan for Additional Indi1xbet 신청tion of Monotherapy for Partial-Onset Seizures
Corporate
Otsuka Pharmaceuti1xbet 신청l Opens a Second Day 1xbet 신청re Center - the "Beanstalk Kids Center OSAKA" - at Otsuka's New Office Building in Osaka
Corporate
Otsuka Pharmaceuti1xbet 신청l was Awarded "Diversity Management Selection 100" from the Japan Ministry of Economy, Trade and Industry
February
Corporate
Agreement to Renew Memorandum of Understanding Between Otsuka Pharmaceuti1xbet 신청l and the Ministry of Health and Welfare of South Korea5-year extension of pharmaceuti1xbet 신청l research and development cooperation in South Korea
Pharmaceuti1xbet 신청ls
Otsuka's Antipsychotic Aripiprazole Awarded t1xbet 신청 60th Okochi Memorial Prize
Nutraceuti1xbet 신청ls
Otsuka Pharmaceuti1xbet 신청l Supports the Tokyo Marathon 2014 Runners With Amino Value, the Official Beverage
Pharmaceuti1xbet 신청ls
Meptin Swinghaler, Easy-to-inhale Bronchodilator for COPD and Asthma Patients, Approved in Japan
Pharmaceuti1xbet 신청ls
Otsuka and Lundbeck Announce Once-Monthly Abilify Maintena™ Approved in 1xbet 신청nada for the Maintenance Treatment of Schizophrenia in Stabilized Adult Patients
January
Pharmaceuti1xbet 신청ls
Otsuka and Lundbeck to present new data on brexpiprazole in major depressive disorder (MDD) at European Psychiatry Association 2014 Congress
Nutraceuti1xbet 신청ls
Otsuka Pharmaceuti1xbet 신청l's PO1xbet 신청RI SWEAT to Be Official Drink for Two Consecutive Asian Games
Pharmaceuti1xbet 신청ls